SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-14-005102
Filing Date
2014-01-30
Accepted
2014-01-30 20:00:33
Documents
1
Period of Report
2014-01-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v366690_3.html 3  
1 OWNERSHIP DOCUMENT v366690_3.xml 3 1538
  Complete submission text file 0001144204-14-005102.txt   2989
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O CHELSEA THERAPEUTICS, INC. 13950 BALLANTYNE CORPORATE PL, UNIT 325 CHARLOTTE NC 28277
Business Address
Schmidt Keith (Reporting) CIK: 0001389235 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51462 | Film No.: 14562349